TP53 and melanoma: Marais et al reported that BRAF depletion can suppress MEK/ERK signalling to mediate p53‐dependent apoptosis in melanoma cells, whereas CRAF might compensate for BRAF depletion to maintain melanoma cell viability via regulating DNA synthesis.8